Opens in a new tab

10x Genomics v Curio Bioscience (CFI, 20 February 2025)

Date20 February 2025
CourtCFI
DivisionDüsseldorf (DE) Local Division
Type of actionGeneric application
Registry referenceApp_2588/2025 · ORD_3005/2025
Parties10x Genomics, Inc.

Official decision (PDF) · UPC registry entry

Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.

Contact the firm

Dhenne Avocats · 10 October 2026

Our analysis

Summary

By procedural order of 20 February 2025 (UPC_CFI_463/2023, ACT_590953/2023, App_2588/2025), the judge-rapporteur of the Düsseldorf Local Division (Presiding Judge Thomas) ordered the Registry to repay to 10x Genomics the EUR 2,000,000 security deposited for enforcement of the provisional measures granted on 30 April 2024 against Curio Bioscience (EP 2 697 391), a bank guarantee having since been provided. The order confirms that a party may replace a cash deposit with a bank guarantee.

Question

Can an applicant that lodged enforcement security as a cash deposit obtain its repayment after providing a bank guarantee?

Decision

Yes. Following Ortovox v Mammut, Düsseldorf Local Division, 5 August 2024, the judge-rapporteur held that the resulting double security can justify a corresponding release, although the applicant’s choice is not unlimited and must be weighed against the interests of the applicant, the defendant and the court. 10x Genomics had a legitimate interest in depositing cash first, so as to enforce the measures promptly, since a bank guarantee could not be obtained as quickly, its US bank not being directly supervised by the ECB. The deposit being economically disadvantageous and the bank guarantee, delivered on 19 December 2024, duly provided, the Registry must repay the sum (Rule 352.2 and Rule 45.3 of the Registry Rules), but only once the time limit for requesting panel review (Rule 333.2) has expired without a request. Curio Bioscience had not commented.

Key points for practice

Provisions applied

Rules of Procedure
Rules 333.2, 352.2 and 354.1
Case law cited
Ortovox v Mammut, Düsseldorf Local Division, 5 August 2024 (UPC_CFI_452/2023).

Prepared by Dhenne Avocats from the official decision, consulted on 10 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.


Going further

Lexicon: Written procedure (UPC), Court fees and costs (UPC).

Source and translations

Official source
Unified Patent Court registry link recorded in the record
Original language
not recorded
Translation available
no translation recorded the firm’s French record is a summary, not a translation
Date checked
not recorded
Only the official text is authoritative. A machine translation is never presented as official, republishing a third-party document requires a verified basis in rights, and a link to the source is preferred.

Follow this case

Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.

Proceedings

No case number recorded in this record.

Parties

Exact name as it appears in the record, group affiliation only where sourced and dated.

Decisions in the same proceedings and documented appeals

No other decision in the corpus bears the same case number, and no appeal is documented in the corpus to date.

What the record states

Nature of the act
Generic application
Outcome (Dhenne Avocats summary)
Le greffe doit restituer la garantie de 2 000 000 euros consignée, une garantie bancaire ayant été remise, sous réserve de l'expiration du délai de révision.
Appeal
No appeal documented in the corpus, this does not mean that no appeal was lodged.
Instance
First-instance decision, whether it has become final is not recorded.

Patents mentioned

Related decisions cited in the analyses

Scope: Dhenne Avocats corpus. Registry-based links are marked “official number”; links derived from the analyses are marked as such. An erroneous link can be withdrawn without deleting any record.

Patents and standards

PublicationRole in the disputeFamilyStandard and declarationPoolSources
EP 2 697 391
Method and product for localised or spatial detection of nucleic acid in a tissue sample
recorded proprietor: Spatial Transcriptomics AB
Mentioned in the analysis (role not qualified)
Also mentioned in 28 other decision(s): 10x Genomics v Curio Bioscience (CFI, ORD_598272/2023, 30 April 2024) · 10x Genomics v Curio Bioscience (CFI, UPC_CFI_658/2025, 2 February 202 · 10x Genomics v Curio Bioscience (CFI, UPC_CFI_657/2025, 2 February 202 · 10x Genomics v Curio Bioscience (CFI, 5 August 2025) · 10x Genomics v Curio Bioscience (CFI, 4 August 2025) · 10x Genomics v Curio Bioscience (CFI, 16 June 2025) · 10x Genomics v Curio Bioscience (CFI, 4 June 2025) · 10x Genomics v Curio Bioscience (CFI, 2 May 2025)
not recordednot recordednot recordedEspacenet · European Patent Register
existence and title of the publication checked on 30 October 2026 (Google Patents, Espacenet and Register links are not checked automatically)
mentioned in: Dhenne Avocats analysis
The statuses “asserted in litigation”, “declared essential”, “listed by a pool” and “essentiality examined by a court” are distinct and may coexist. Validity, infringement and technical essentiality are different questions. Scope: patents cited in the decisions of the Dhenne Avocats corpus, with no essentiality score or prediction.

Receive an alert

Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.

Follow

Weekly summary, on Fridays.